GDUFA Research Outcomes
LAI Products
This section contains scientific publications, presentations, and posters arising from GDUFA-funded research relevant to long-acting injectable, insertable or implantable (collectively, LAI) generic products.
-
From Bench to Approval: the Role of GDUFA Research in Promoting Complex Generics
Wang, Yan
-
Bioequivalence Approaches for Long-Acting Drug Products: Regulatory and Scientific Considerations
Wang, Yan
-
Considerations and Expectations for in Vitro Release Testing of Complex Formulations
Wang, Yan
-
Development of Generic Long Acting Injectables: Regulatory Challenges and Considerations
Wang, Yan
-
Characterization of Complex Excipients and Formulations
Wang, Yan
-
Long Acting Injectable and Implantable Drug Product Development Regulatory Challenges and Considerations_GSK-CRS Conference
Wang, Yan
-
Challenges Associated with Development of Generic PLGAPLA Based Drug Products
Wang, Yan
-
Opportunities and Challenges for Modeling and Simulation in Development of Long-Acting Injectable Drug Products
Sharan, Satish
-
Application of Modeling and Simulation in Establishing Appropriate Bioequivalence Limits for Complex Formulations
Sharan, Satish
-
Evaluation Of Residual Levonorgestrel As Potential Bioequivalence Metric For A Long Acting Intrauterine System Using Quantitative Modeling And Simulation Approach
Sharan, Satish